AIM
TYRA icon

AXA Investment Managers’s Tyra Biosciences TYRA Stock Holding History

AXA Investment Managers’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$1.8M Buy
+128,789
New +$1.47M ﹤0.01% 788

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
APMC
Alta Partners Management Company Jackson, Wyoming $151M AUM 296.21% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
CPX
Canaan Partners XI Menlo Park, California $127M AUM 217.49% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

AXA Investment Managers's TYRA Position: Q3 2025 in Review

AXA Investment Managers opened a new position in Tyra Biosciences (TYRA) in Q3 2025: 128,789 shares worth $1.8M. The stake represents ﹤0.01% of the portfolio and ranks #788 among its holdings.

116 funds tracked by Wall St. Rank hold TYRA as of Q3 2025.

  • AXA Investment Managers held 128,789 shares of Tyra Biosciences worth $1.8M as of Q3 2025.
  • Tyra Biosciences was a new AXA Investment Managers position in Q3 2025.
  • Tyra Biosciences made up ﹤0.01% of AXA Investment Managers's portfolio in Q3 2025, its #788 holding.
  • 116 funds tracked by Wall St. Rank held Tyra Biosciences as of Q3 2025.

Based on AXA Investment Managers's 13F filing for Q3 2025, filed 14 Nov 2025.